What is LymphoSIGHT™?
Lymphocyte Sequencing of Immunoglobulin and T-cell Receptors
The LymphoSIGHT platform from Sequenta combines proprietary multiplexed PCR assays and powerful algorithms for analysis of next-generation sequencing data. The result is a simple and scalable laboratory process that allows each of the several million B- and T-cells (lymphocytes) in a blood or tissue sample to be characterized and enumerated.
The LymphoSIGHT method utilizes proprietary multiplexed PCR assays for the universal amplification of rearranged immunoglobulin and T-cell receptor genes. The assay does not require patient-specific customization, which improves scalability and reduces costs.
Following sequencing, the LymphoSIGHT method enables the absolute quantitation of individual B and T cells.